General Information of the Compound
| Compound ID |
CP0439514
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(8S,11R,13S,14R,17S)-11-(4-dimethylamino-phenyl)-17-(3-dimethylamino-prop-1-ynyl)-17-hydroxy-13-methyl-1,2,8,11,12,13,14,15,16,17-decahydro-6H-7-oxa-cyclopenta[a]phenanthren-3-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H38N2O3
|
||||||||||||||||||
| Molecular Weight |
474.645
|
||||||||||||||||||
| Canonical SMILES |
CN(C)CC#C[C@]1(O)CC[C@H]2[C@@H]3OCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H38N2O3/c1-29-18-25(20-7-9-22(10-8-20)32(4)5)27-24-12-11-23(33)17-21(24)19-35-28(27)26(29)13-15-30(29,34)14-6-16-31(2)3/h7-10,17,25-26,28,34H,11-13,15-16,18-19H2,1-5H3/t25-,26+,28+,29+,30+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZOJNIVLVFGPWTA-LXEMEFDRSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00967, Glucocorticoid receptor
Protein ID: PT01172, Progesterone receptor